Efficacy of intrauterine administration of autologous peripheral blood mononuclear cells prior to embryo transfer in patients with recurrent implantation failures in assisted reproductive technology programmes

• Published in: Ginekologiâ (Moskva. Online) Vol. 20; no. 2; pp. 28 - 33
• Main Authors: Amyan, T S, Perminova, S G, Krechetova, L V, Vtorushina, V V
• Format: Journal Article
• Language: English; Russian
• Published: IP Berlin A.V 15.04.2018
• Subjects: autologous peripheral blood mononuclear cells; hcg; intrauterine administration; recurrent implantation failures
• ISSN: 2079-5696; 2079-5831
• DOI: 10.26442/2079-5696_2018.2.28-33

Study objective. To evaluate the efficacy of intrauterine administration of autologous peripheral blood mononuclear cells (PBMC) prior to embryo transfer in patients with recurrent implantation failures in IVF program. Materials and methods. The study enrolled 129 patients with recurrent implantation failures in an IVF programme. Group 1 - 42 patients who had intrauterine administration of autologous PBMC activated with hCG (Pregnyl 500 IU). Group 2 - 42 patients who had intrauterine administration of autologous PBMC without hCG activation. Group 3 (placebo) - 45 patients who had intrauterine administration of saline. Study results. In the hCG-activated PBMC group, the rates of positive blood hCG tests, implantation, and clinical pregnancy were significantly higher than the respective rates in the non-activated PBMC group and in the placebo group, both in a stimulated cycle and in an FET cycle (р≤0.05). Conclusion. Intrauterine administration of autologous PBMC prior to embryo transfer in an IVF/ICSI programme increases the efficacy of IVF program in patients with a history of recurrent implantation failures.